AmideBio LLC
The University of Colorado Connection
AmideBio is a biopharmaceutical spinout company co-founded by Michael Stowell (CU Boulder Molecular, Cellular and Developmental Biology). AmideBio was launched to commercialize Stowell's proprietary BioPure™ platform technology, a novel and cost-effective method for the recombinant manufacturing of complex, difficult-to-produce peptides and proteins. AmideBio has since expanded its focus to include drug development for metabolic disease, including diabetes.
Funding Status and Investment Opportunities
- Industry Applications: Health and Wellness, Biotech, Therapeutics
- Funding Round: Series A
- Contact for Investment Inquiries: info@amidebio.com
In the News
Venture Partners Programs
- Bioscience Discovery and Evaluation Grant Program (now Lab Venture Challenge) (2010)
- Intellectual Property Management (2008)
Technology Development Funding
Arnold & Mabel Beckman Foundation
This page was last updated on Feb. 5, 2026. Please email vpnews@colorado.edu for corrections or updates
The Insider Investor eNewsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard, senior marketing and communications specialist for Venture Partners at CU Boulder.
For media inquiries, please visit colorado.edu/news/formedia.